BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28777670)

  • 21. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
    Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
    Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
    Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
    Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
    Zhang HP; Yu ZL; Wu BB; Sun FR
    J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.
    Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Wang Y; Deng Y
    J Physiol Biochem; 2020 May; 76(2):279-290. PubMed ID: 32100243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
    Liu Y; Cheng Z; Pan F; Yan W
    Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway.
    Han W; Liu J
    Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway.
    Tong Z; Shen Y; Yuan Q; Yu H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
    Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
    Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
    Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH
    Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
    Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
    Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway.
    Chen H; Pan R; Li H; Zhang W; Ren C; Lu Q; Chen H; Zhang X; Nie Y
    Cell Biol Int; 2021 Mar; 45(3):623-632. PubMed ID: 33245175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway.
    Jiang M; Lu W; Ding X; Liu X; Guo Z; Wu X
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30643010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN Plays Dual Roles As a Tumor Suppressor in Osteosarcoma Cells.
    Xi Y; Chen Y
    J Cell Biochem; 2017 Sep; 118(9):2684-2692. PubMed ID: 28106296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.
    Wang L; Yang L; Lu Y; Chen Y; Liu T; Peng Y; Zhou Y; Cao Y; Bi Z; Liu T; Liu Z; Shan H
    Cell Physiol Biochem; 2016; 38(6):2173-82. PubMed ID: 27185245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
    Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
    Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
    Zhu J; Liu F; Wu Q; Liu X
    Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.